Review Article
Rise of Clinical Trials Industry in India: An Analysis
Table 2
Financials for US Corporations Marketing the Top 50 Drugs for Seniors, 2001.
| Company | Revenue (net sales in millions of dollars) | Percent of revenue allocated to | Marketing/advertising/administration | R & D | Profit (not income) |
| Merk and Co. Inc | 40,363 | 15% | 6% | 17% | Pfizer Inc. | 29,574 | 39% | 15% | 13% | Bristol-Meyers Squibb company | 18,216 | 30% | 11% | 26% | Pharmacia corporation | 18,144 | 37% | 15% | 4% | Abbott laboratories | 13,746 | 21% | 10% | 20% | American home products corporation | 13,262 | 38% | 13% | ā18% | Eli lilly and Co. | 10,862 | 30% | 19% | 28% | Schering-plough corporation | 9,815 | 36% | 14% | 25% | Allergan Inc. | 1,563 | 42% | 13% | 14% |
| Total (dollars in millions) | $166,678 | 27% ($45,413) | 11% ($19,076) | 18% ($30,599) |
|
|
Source: Families USA (2002): [47].
|